These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

361 related articles for article (PubMed ID: 34250319)

  • 1. Review of Early Immune Response to SARS-CoV-2 Vaccination Among Patients With CKD.
    Carr EJ; Kronbichler A; Graham-Brown M; Abra G; Argyropoulos C; Harper L; Lerma EV; Suri RS; Topf J; Willicombe M; Hiremath S
    Kidney Int Rep; 2021 Sep; 6(9):2292-2304. PubMed ID: 34250319
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term efficacy and safety of SARS-CoV-2 vaccination in patients with chronic kidney disease, on dialysis or after kidney transplantation: a national prospective observational cohort study.
    Bouwmans P; Messchendorp AL; Sanders JS; Hilbrands L; Reinders MEJ; Vart P; Bemelman FJ; Abrahams AC; van den Dorpel MA; Ten Dam MA; de Vries APJ; Rispens T; Steenhuis M; Gansevoort RT; Hemmelder MH;
    BMC Nephrol; 2022 Feb; 23(1):55. PubMed ID: 35123437
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Humoral and cellular immune response and the safety of third SARS-CoV-2 mRNA vaccine with longer interval after the second vaccination in kidney transplant recipients.
    Takai S; Nishida H; Ito H; Fukuhara H; Nawano T; Narisawa T; Kanno H; Yagi M; Yamagishi A; Sakurai T; Naito S; Kato T; Morikane K; Tsuchiya N
    Front Immunol; 2022; 13():1050211. PubMed ID: 36532067
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Humoral and cellular immunity to SARS-CoV-2 vaccination in renal transplant versus dialysis patients: A prospective, multicenter observational study using mRNA-1273 or BNT162b2 mRNA vaccine.
    Stumpf J; Siepmann T; Lindner T; Karger C; Schwöbel J; Anders L; Faulhaber-Walter R; Schewe J; Martin H; Schirutschke H; Barnett K; Hüther J; Müller P; Langer T; Pluntke T; Anding-Rost K; Meistring F; Stehr T; Pietzonka A; Escher K; Cerny S; Rothe H; Pistrosch F; Seidel H; Paliege A; Beige J; Bast I; Steglich A; Gembardt F; Kessel F; Kröger H; Arndt P; Sradnick J; Frank K; Klimova A; Mauer R; Grählert X; Anft M; Blazquez-Navarro A; Westhoff TH; Stervbo U; Tonn T; Babel N; Hugo C
    Lancet Reg Health Eur; 2021 Oct; 9():100178. PubMed ID: 34318288
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Virus-Subtype-Specific Cellular and Humoral Immune Response to a COVID-19 mRNA Vaccine in Chronic Kidney Disease Patients and Renal Transplant Recipients.
    Knell AI; Böhm AK; Jäger M; Kerschbaum J; Engl S; Rudnicki M; Buchwinkler L; Bellmann-Weiler R; Posch W; Weiss G
    Microorganisms; 2023 Jul; 11(7):. PubMed ID: 37512928
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Humoral and cellular immune response to SARS-CoV-2 mRNA BNT162b2 vaccine in pediatric kidney transplant recipients compared with dialysis patients and healthy children.
    Gulmez R; Ozbey D; Agbas A; Aksu B; Yildiz N; Uckardes D; Saygili S; Yilmaz EK; Yildirim ZY; Tasdemir M; Kiykim A; Cokugras H; Canpolat N; Nayir A; Kocazeybek B; Caliskan S
    Pediatr Nephrol; 2023 Jul; 38(7):2199-2208. PubMed ID: 36459243
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impaired Immune Response to SARS-CoV-2 Vaccination in Dialysis Patients and in Kidney Transplant Recipients.
    Kolb T; Fischer S; Müller L; Lübke N; Hillebrandt J; Andrée M; Schmitz M; Schmidt C; Küçükköylü S; Koster L; Kittel M; Weiland L; Dreyling KW; Hetzel G; Adams O; Schaal H; Ivens K; Rump LC; Timm J; Stegbauer J
    Kidney360; 2021 Sep; 2(9):1491-1498. PubMed ID: 35373105
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cellular and humoral immune response after mRNA-1273 SARS-CoV-2 vaccine in liver and heart transplant recipients.
    Herrera S; Colmenero J; Pascal M; Escobedo M; Castel MA; Sole-González E; Palou E; Egri N; Ruiz P; Mosquera M; Moreno A; Juan M; Vilella A; Soriano A; Farrero M; Bodro M
    Am J Transplant; 2021 Dec; 21(12):3971-3979. PubMed ID: 34291552
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-Term Humoral Response After a Second Dose of SARS-CoV-2 mRNA Vaccine in Japanese Kidney Transplant Recipients.
    Ohki Y; Kawabe M; Yamamoto I; Katsumata H; Nakada Y; Kobayashi A; Urabe F; Miki J; Yamada H; Kimura T; Matsuo N; Tanno Y; Horino T; Ohkido I; Yamamoto H; Yokoo T
    Front Microbiol; 2022; 13():922042. PubMed ID: 35756063
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Augmented humoral and cellular immunity against severe acute respiratory syndrome coronavirus 2 after breakthrough infection in kidney transplant recipients who received 3 doses of coronavirus disease 2019 vaccine.
    Yang J; Lee KW; Baek JY; Bae S; Lee YH; Kim H; Huh K; Cho SY; Kang CI; Chung DR; Peck KR; Park JB; Kim SH; Kim TJ; Kim DM; Ko JH
    Am J Transplant; 2023 Apr; 23(4):565-572. PubMed ID: 36739177
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insufficient response to mRNA SARS-CoV-2 vaccine and high incidence of severe COVID-19 in kidney transplant recipients during pandemic.
    Reischig T; Kacer M; Vlas T; Drenko P; Kielberger L; Machova J; Topolcan O; Kucera R; Kormunda S
    Am J Transplant; 2022 Mar; 22(3):801-812. PubMed ID: 34860470
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Humoral Response after SARS-CoV-2 mRNA Vaccination in a Cohort of Hemodialysis Patients and Kidney Transplant Recipients.
    Danthu C; Hantz S; Dahlem A; Duval M; Ba B; Guibbert M; El Ouafi Z; Ponsard S; Berrahal I; Achard JM; Bocquentin F; Allot V; Rerolle JP; Alain S; Touré F
    J Am Soc Nephrol; 2021 Sep; 32(9):2153-2158. PubMed ID: 34135083
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunogenicity and safety of two doses of SARS-CoV-2 mRNA vaccine in kidney transplant recipients with low-dose rituximab.
    Takai S; Nishida H; Ito H; Fukuhara H; Nawano T; Narisawa T; Kanno H; Yagi M; Yamagishi A; Sakurai T; Naito S; Kato T; Morikane K; Tsuchiya N
    Int J Urol; 2022 Nov; 29(11):1279-1286. PubMed ID: 35863901
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A randomized, double-blind, placebo-controlled phase III clinical trial to evaluate the efficacy and safety of SARS-CoV-2 vaccine (inactivated, Vero cell): a structured summary of a study protocol for a randomised controlled trial.
    Akova M; Unal S
    Trials; 2021 Apr; 22(1):276. PubMed ID: 33849629
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Determining the Longitudinal Serologic Response to COVID-19 Vaccination in the Chronic Kidney Disease Population: A Clinical Research Protocol.
    Yau K; Enilama O; Levin A; Romney MG; Singer J; Blake P; Perl J; Leis JA; Kozak R; Tsui H; Bolotin S; Tran V; Chan CT; Tam P; Dhruve M; Kandel C; Estrada-Codecido J; Brown T; Siwakoti A; Abe KT; Hu Q; Colwill K; Gingras AC; Oliver MJ; Hladunewich MA
    Can J Kidney Health Dis; 2023; 10():20543581231160511. PubMed ID: 36950028
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of Potent Cellular and Humoral Immune Responses in Long-Term Hemodialysis Patients After 1273-mRNA SARS-CoV-2 Vaccination.
    Gonzalez-Perez M; Montes-Casado M; Conde P; Cervera I; Baranda J; Berges-Buxeda MJ; Perez-Olmeda M; Sanchez-Tarjuelo R; Utrero-Rico A; Lozano-Ojalvo D; Torre D; Schwarz M; Guccione E; Camara C; Llópez-Carratalá MR; Gonzalez-Parra E; Portoles P; Ortiz A; Portoles J; Ochando J
    Front Immunol; 2022; 13():845882. PubMed ID: 35401504
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immune Response to Third and Fourth COVID-19 Vaccination in Hemodialysis Patients and Kidney Transplant Recipients.
    Affeldt P; Koehler FC; Brensing KA; Gies M; Platen E; Adam V; Butt L; Grundmann F; Heger E; Hinrichs S; Kalisch N; Oehm S; Steger G; Wirtz M; Benzing T; Stippel D; Klein F; Kurschat C; Müller RU; Di Cristanziano V
    Viruses; 2022 Nov; 14(12):. PubMed ID: 36560648
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety and Efficacy of the COVID-19 Vaccine in Kidney Transplant Recipients.
    Altheaby A; Alloqmani D; AlShammari R; Alsuhaibani A; Hakeem A; Alam S; Alharbi S; Al Zunitan M; Bosaeed M; Alharbi NK
    Cureus; 2022 May; 14(5):e24753. PubMed ID: 35686249
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Humoral Response After SARS-CoV-2 Vaccination in Kidney Transplant Recipients: Role of Immunosuppression Therapy.
    López V; Polo C; Schuldt R; Vázquez T; Gutiérrez-Vílchez E; Moliz C; Hernández D
    Transplant Proc; 2022 Nov; 54(9):2454-2456. PubMed ID: 36273957
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunity after COVID-19 vaccination in people with higher risk of compromised immune status: a scoping review.
    Kreuzberger N; Hirsch C; Andreas M; Böhm L; Bröckelmann PJ; Di Cristanziano V; Golinski M; Hausinger RI; Mellinghoff S; Lange B; Lischetzki T; Kappler V; Mikolajewska A; Monsef I; Park YS; Piechotta V; Schmaderer C; Stegemann M; Vanshylla K; Weber F; Weibel S; Stephani C; Skoetz N
    Cochrane Database Syst Rev; 2022 Aug; 8(8):CD015021. PubMed ID: 35943061
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.